Hecht v. Kaplan

221 A.D.2d 100, 645 N.Y.S.2d 51, 1996 N.Y. App. Div. LEXIS 7198
CourtAppellate Division of the Supreme Court of the State of New York
DecidedJune 17, 1996
StatusPublished
Cited by22 cases

This text of 221 A.D.2d 100 (Hecht v. Kaplan) is published on Counsel Stack Legal Research, covering Appellate Division of the Supreme Court of the State of New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Hecht v. Kaplan, 221 A.D.2d 100, 645 N.Y.S.2d 51, 1996 N.Y. App. Div. LEXIS 7198 (N.Y. Ct. App. 1996).

Opinion

OPINION OF THE COURT

Florio, J.

In December 1990, the plaintiff Trudy Hecht went to the office of the defendant Dr. Mark Kaplan located at the codefendant North Shore University Hospital to have blood withdrawn for the purpose of testing for cytomegalovirus (hereinafter CMV). Two vials of blood were drawn. The blood was tested for CMV and, unbeknownst to Trudy Hecht, was also tested for Human T-cell Leukemia Virus (hereinafter HTLV), a contagious disease. The test indicated that Trudy Hecht was infected with HTLV. The defendants did not inform the plaintiffs of the results of the HTLV test for several months.

Sometime after learning of the HTLV test and its results, the plaintiffs commenced this medical malpractice action in June 1992 by summons and complaint alleging, inter alia, that the defendants had not obtained Trudy Hecht’s consent to draw blood for HTLV testing, that Dr. Kaplan’s use of the test results of Trudy Hecht amounted to human research without her consent, that the delay in informing the plaintiffs of those test results endangered the health of Kenneth Hecht, and negligence. The plaintiffs moved, among other things, for partial summary judgment and the defendants cross-moved to dismiss the complaint on various grounds. The Supreme Court denied the branch of the defendants’ cross motion which was [103]*103to dismiss those causes of action which were based on lack of informed consent, nonconsensual experimentation, and failure to promptly inform the plaintiffs of the test results. The Supreme Court, while granting the branch of the defendants’ motion which was to dismiss the plaintiffs’ sixth and seventh causes of action, granted the plaintiffs leave to replead those causes of action to assert a cause of action sounding in negligence. We disagree with these determinations and therefore reverse.

The record establishes that in the course of drawing Trudy Hecht’s blood (with her consent), to test that blood for the presence of CMV, an additional tube of blood, which may not have been needed for the CMV blood test, was also drawn without any further invasive procedure. Further, the record reveals that Trudy Hecht’s blood was subsequently tested without her consent for the presence of HTLV. The plaintiffs also assert that the defendants failed to timely notify them of the results of such testing. Based upon these facts and allegations, we find that the plaintiffs’ complaint fails to state a cause of action as to the first, third, and fifth causes of action in the complaint.

In a cause of action to recover damages for medical malpractice which is based upon a claim of lack of informed consent, the pleadings must establish, inter alia, that there was some unconsented-to affirmative violation of the plaintiff’s physical integrity (see, Public Health Law § 2805-d [2] [b]; Iazzetta v Vicenzi, 200 AD2d 209; Keselman v Kingsboro Med. Group, 156 AD2d 334; see generally, Rovello v Orofino Realty Co., 40 NY2d 633).

While the exact circumstances relating to the plaintiffs’ cause of action to recover damages for lack of informed consent have not been considered by the courts of our State, the Pennsylvania Superior Court dealt with a somewhat similar factual pattern in Doe v Dyer-Goode (389 Pa Super 151, 566 A2d 889), and we draw upon it for guidance here. In Doe, the plaintiff consented to have blood drawn for certain tests. That blood was then also tested, without Doe’s consent, for the presence of HIV. Upon learning of the test and the positive results (it should be noted that six months later, the results of a new blood test were negative), Doe sued the doctor who drew the blood and directed that the initial test for HIV be performed. In the complaint, Doe asserted a number of theories, including, inter alia, lack of informed consent. The Pennsylvania Superior Court dismissed the complaint, including the cause of action [104]*104sounding in lack of informed consent. Insofar as it is relevant to this case, the Pennsylvania Superior Court found that since there was no allegation that Doe was not informed of the risks relating to the procedure itself, i.e., the drawing of blood, the fact that an additional test was performed was insufficient to permit an action grounded in battery (i.e., lack of informed consent) to stand (Doe v Dyer-Goode, 389 Pa Super, supra, at 158, 566 A2d, supra, at 891-892).

The California case of Moore v Regents of Univ. of Cal. (51 Cal 3d 120, 793 P2d 479), which upheld causes of action to recover damages for lack of informed consent and breach of fiduciary duty based upon the taking of unauthorized blood samples, is factually inapposite. There, many blood samples were drawn over a period of months and for a purpose unrelated to the patient’s original problem and purely for the defendants’ research purposes. In contrast, in the instant case, the possibly unauthorized additional blood sample was drawn only once and during the course of an unquestionably consented-to procedure and was used at least partially to benefit the plaintiffs.

We find that merely drawing an extra tube of blood during the course of an otherwise proper blood test, even for the purpose of performing unauthorized testing upon it, does not constitute an affirmative violation of Trudy Hecht’s physical integrity. Therefore, since no such violation occurred, the plaintiffs’ complaint fails to state a cause of action based upon lack of informed consent and that cause of action should have been dismissed.

We also find that the plaintiffs’ allegations are insufficient to state a cause of action under Public Health Law § 2442 for unauthorized human research.

" 'Human research’ ” is defined in Public Health Law § 2441 (2) as "any medical experiments, research * * * which utilizes human subjects * * * and which is not required for the purposes of obtaining information for the diagnosis * * * or the assessment of [the] medical condition for the direct benefit of the subject. Human research shall not, however, be construed to mean the conduct of biological studies exclusively utilizing tissue or fluids after their * * * withdrawal * * * in the course of standard medical practice”.

Public Health Law § 2442 states: "No human research may be conducted in this state in the absence of the voluntary informed consent”.

Viewed in the light most favorable to them, the plaintiffs’ allegations as to any alleged human research performed by the [105]*105defendants are insufficient as a matter of law. The plaintiff Trudy Hecht merely asserts that the defendant, Dr. Kaplan, performed, without her consent, an HTLV test on blood that had been withdrawn from her during the course of testing her for the presence of CMV, a procedure she had consented to. Her verified bill of particulars essentially reiterates those allegations.

Therefore, based upon the plaintiffs’ own allegations, it is undeniable that the HTLV test was performed only upon blood which had already been drawn from Trudy Hecht during the course of standard medical practice. Therefore, the defendants’ actions do not fit within the definition of human research. Accordingly, the plaintiffs failed to state a cause of action under Public Health Law § 2442.

We also find that the defendants did not breach any duty of care owed to the plaintiff, Kenneth Hecht, due to their alleged failure to promptly inform him that his wife, Trudy Hecht, was infected with HTLV.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Pinnock v. Mercy Med. Ctr.
2020 NY Slip Op 1374 (Appellate Division of the Supreme Court of New York, 2020)
Samer v. Desai
2020 NY Slip Op 318 (Appellate Division of the Supreme Court of New York, 2020)
Greene v. Esplanade Venture Partnership
2019 NY Slip Op 3771 (Appellate Division of the Supreme Court of New York, 2019)
Thomas v. Farrago
2017 NY Slip Op 7292 (Appellate Division of the Supreme Court of New York, 2017)
Routh v. University of Rochester
981 F. Supp. 2d 184 (W.D. New York, 2013)
Entler v. Koch
85 A.D.3d 1098 (Appellate Division of the Supreme Court of New York, 2011)
Ellis v. Eng
70 A.D.3d 887 (Appellate Division of the Supreme Court of New York, 2010)
Aberbach v. Biomedical Tissue Services, Ltd.
48 A.D.3d 716 (Appellate Division of the Supreme Court of New York, 2008)
Herrgesell v. Genesee Hospital
45 A.D.3d 1488 (Appellate Division of the Supreme Court of New York, 2007)
Daluise v. Sottile
40 A.D.3d 801 (Appellate Division of the Supreme Court of New York, 2007)
Guiles v. Simser
9 Misc. 3d 1083 (New York Supreme Court, 2005)
Candelario v. Teperman
15 A.D.3d 204 (Appellate Division of the Supreme Court of New York, 2005)
Martin v. Hudson Valley Associates
13 A.D.3d 419 (Appellate Division of the Supreme Court of New York, 2004)
Jaycox v. Reid
5 A.D.3d 994 (Appellate Division of the Supreme Court of New York, 2004)
Greenberg v. MIAMI CHILDREN'S HOSPITAL RES. INST., INC.
264 F. Supp. 2d 1064 (S.D. Florida, 2003)
Camadeo v. Leeds
290 A.D.2d 355 (Appellate Division of the Supreme Court of New York, 2002)
Perry v. Valley Cottage Animal Hospital
261 A.D.2d 522 (Appellate Division of the Supreme Court of New York, 1999)
Schel v. Roth
242 A.D.2d 697 (Appellate Division of the Supreme Court of New York, 1997)

Cite This Page — Counsel Stack

Bluebook (online)
221 A.D.2d 100, 645 N.Y.S.2d 51, 1996 N.Y. App. Div. LEXIS 7198, Counsel Stack Legal Research, https://law.counselstack.com/opinion/hecht-v-kaplan-nyappdiv-1996.